Last checked at 
(Sharecast News) - AstraZeneca announced on Wednesday, alongside its partner MSD, that 'Lynparza', or olaparib, has been approved in the European Union for patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer.
The FTSE 100 pharmaceuticals giant described pancreatic cancer as a rare, life-threatening disease with the lowest survival rate among the most common cancers.
Between 5% and 7% of patients with metastatic pancreatic cancer have a germline BRCA mutation.
The company said the approval by the European Commission was based on results from the phase 3 'POLO' trial, as published in the New England Journal of Medicine.
It followed the recommendation for approval by the European Medicines Agency's Committee for Medicinal Products for Human Use.
"Today's approval opens the door to a new era of biomarker-led care for patients with metastatic pancreatic cancer in the EU, which has the highest incidence of any region globally," said Hedy Kindler, co-principal investigator of the POLO trial and professor of medicine at the University of Chicago Medicine.
"Lynparza now provides clinicians with a targeted, well-tolerated treatment option for patients with germline BRCA-mutated metastatic pancreatic cancer."
Dave Fredrickson, executive vice-president of AstraZeneca's oncology business unit, added that metastatic pancreatic cancer had historically faced poor outcomes, due to the aggressive nature of the disease and the few treatment advances made in recent decades.
"In the POLO trial, Lynparza nearly doubled median progression-free survival versus placebo after first-line chemotherapy for patients with germline BRCA-mutated metastatic pancreatic cancer.
"This approval underscores the importance of testing all patients for germline BRCA mutations at the time of diagnosis, as it will help inform personalised treatment options for patients in the EU."
AstraZeneca said the POLO trial demonstrated that Lynparza nearly doubled the time patients with gBRCAm metastatic pancreatic cancer lived without disease progression or death, to a median of 7.4 months, compared to 3.8 months on placebo.
It is approved in the United States and several other countries as a first-line maintenance treatment for patients with gBRCAm metastatic pancreatic cancer, based on the phase 3 POLO trial, with ongoing regulatory reviews in other regions.
18 Mar 2024 16:09
UK dividends calendar - next 7 days
| Tuesday 19 March | |
| Jarvis Securities PLC | dividend payment date |
| Wednesday 20 March | |
| Virgin Money UK PLC | dividend payment date |
| Thursday 21 March | |
| abrdn Asia Focus PLC | dividend payment date |
| abrdn Private Equity Opportunities Trust PLC | ex-dividend payment date |
| AIB Group PLC | ex-dividend payment date |
| Beazley PLC | ex-dividend payment date |
| BlackRock World Mining Trust PLC | ex-dividend payment date |
| British American Tobacco PLC | ex-dividend payment date |
| Chemring Group PLC | ex-dividend payment date |
| CLS Holdings PLC | ex-dividend payment date |
| Conduit Holdings Ltd | ex-dividend payment date |
| Craneware PLC | ex-dividend payment date |
| Crest Nicholson Holdings PLC | ex-dividend payment date |
| Diverse Income Trust PLC | ex-dividend payment date |
| Fonix Mobile PLC | ex-dividend payment date |
| FW Thorpe PLC | ex-dividend payment date |
| Glanbia PLC | ex-dividend payment date |
| GlobalData PLC | ex-dividend payment date |
| Globalworth Real Estate Investments Ltd | ex-dividend payment date |
| Goodwin PLC | ex-dividend payment date |
| Gore Street Energy Storage Fund PLC | ex-dividend payment date |
| Hargreaves Services PLC | ex-dividend payment date |
| HgCapital Trust PLC | ex-dividend payment date |
| Hikma Pharmaceuticals PLC | ex-dividend payment date |
| Jardine Matheson Holdings LD | ex-dividend payment date |
| London Finance & Investment Group PLC | ex-dividend payment date |
| Maven Income & Growth VCT 3 PLC | ex-dividend payment date |
| Maven Income & Growth VCT 5 PLC | ex-dividend payment date |
| MTI Wireless Edge Ltd | ex-dividend payment date |
| Nichols PLC | ex-dividend payment date |
| NWF Group PLC | ex-dividend payment date |
| Palace Capital PLC | ex-dividend payment date |
| Pearson PLC | ex-dividend payment date |
| Pembroke VCT B PLC | ex-dividend payment date |
| Primorus Investments PLC | ex-dividend payment date |
| Schroders PLC | ex-dividend payment date |
| Triple Point Energy Transition PLC | ex-dividend payment date |
| Tristel PLC | ex-dividend payment date |
| VPC Specialty Lending Investments PLC | dividend payment date |
| Friday 22 March | |
| easyJet PLC | dividend payment date |
| FRP Advisory Group PLC | dividend payment date |
| Gulf Investment Fund PLC | dividend payment date |
| Henderson Opportunities Trust PLC | dividend payment date |
| Hercules Site Services PLC | dividend payment date |
| Impax Asset Management Group PLC | dividend payment date |
| JLEN Environmental Assets Group Ltd | dividend payment date |
| JPMorgan Multi-Asset Growth & Income PLC | dividend payment date |
| Mattioli Woods PLC | dividend payment date |
| Mobeus Income & Growth 2 VCT PLC | dividend payment date |
| Mobeus Income & Growth 4 VCT PLC | dividend payment date |
| Ramsdens Holdings PLC | dividend payment date |
| Riverstone Credit Opportunities Income PLC | dividend payment date |
| Ruffer Investment Co Ltd | dividend payment date |
| Samuel Heath & Sons PLC | dividend payment date |
| Troy Income & Growth Trust PLC | dividend payment date |
| Unilever PLC | dividend payment date |
| Monday 25 March | |
| AstraZeneca PLC | dividend payment date |
| Endeavour Mining PLC | dividend payment date |
| Mountview Estates PLC | dividend payment date |
| Shell PLC | dividend payment date |
| Comments and questions to newsroom@alliancenews.com | |
| A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional. | |
| Copyright 2024 Alliance News Ltd. All Rights Reserved. | |